- Clinical trials are research studies that test whether a new treatment is safe and effective; they are not guaranteed therapy.
- Drug trials generally move through phases (roughly 1 to 4), each answering different questions about safety, dosing, and effectiveness.
- You can search current psoriasis studies on ClinicalTrials.gov, a US government registry of clinical studies.
- Informed consent means you receive full information, can ask questions, and can withdraw at any time.
- Eligibility rules (inclusion and exclusion criteria) determine who can join a given trial.
- Discuss any trial with your own dermatologist, and never stop your current psoriasis treatment on your own to qualify.
Psoriasis is a chronic immune-mediated skin condition, and research into new treatments is active, ranging from biologic medications to oral drugs and topical therapies. For some people, especially when psoriasis is moderate to severe or has not responded well to standard care, a clinical trial can be one way to access investigational treatments while contributing to research. But trials are research studies, not guaranteed therapy. This guide explains how psoriasis clinical trials work, what the phases mean, how to search for studies, and what informed consent involves, so you can have a well-prepared conversation with your dermatologist.
What a clinical trial actually is
A clinical trial is a research study that tests a medical approach, such as a new medication, biologic, or topical treatment, in people. The goal is to answer specific questions: Is it safe? What dose works best? Does it help more than existing options or a placebo? Because those questions are still being answered, participation always involves some uncertainty. A trial is designed to generate knowledge; participants may benefit, but benefit is never guaranteed and is not the study’s only purpose.
For psoriasis specifically, studies may test new systemic biologics, small-molecule oral drugs, topical formulations, light-based therapies, or treatments aimed at related conditions such as psoriatic arthritis. Some trials focus on people whose plaques have not cleared with standard treatments.
The phases of drug trials
New drugs generally move through a series of phases, each asking a different question. Understanding them helps set realistic expectations.
| Phase | Main question | Typical scope |
|---|---|---|
| Phase 1 | Is it safe, and what dose is tolerable? | Small group of participants |
| Phase 2 | Does it appear to work, and what are the side effects? | Larger group |
| Phase 3 | Is it effective compared with standard care or placebo? | Large groups, often multiple sites |
| Phase 4 | What are the longer-term effects after approval? | Post-approval monitoring |
Many trials use a control group and randomization, and some are “blinded,” meaning participants (and sometimes researchers) do not know who receives the investigational treatment versus a comparison or placebo. These designs help produce reliable answers, but they also mean you may not receive the new treatment.
How to search for psoriasis trials
The main US resource is ClinicalTrials.gov, a registry maintained by the National Institutes of Health that lists clinical studies conducted around the world. You can search by condition (such as “psoriasis” or “plaque psoriasis”), location, and recruitment status. Each listing describes the study’s purpose, eligibility criteria, locations, and contact information.
Academic dermatology centers and patient advocacy organizations may also share trial opportunities. As you read listings, look closely at the eligibility rules: inclusion criteria (characteristics you must have to join) and exclusion criteria (things that would keep you out), which often include psoriasis type and severity, age, prior treatments, and other health conditions. If you are also exploring related skin-condition research, our overview of clinical trials for eczema follows the same structure, and our wellness guides take an evidence-first approach throughout.
Informed consent and your rights
Before joining any trial, you go through informed consent. The research team must explain the study’s purpose, procedures, potential risks and benefits, alternatives, and what is expected of you, in language you can understand, and give you time to ask questions. Key protections include:
- Participation is voluntary, and you can decline without affecting your regular care.
- You can withdraw from a study at any time, for any reason.
- Trials are reviewed by an independent ethics board (an Institutional Review Board) to help protect participants.
- You should understand any costs, travel, time commitment, and what happens to your treatment when the study ends.
Consent is an ongoing conversation, not just a signature. Ask as many questions as you need. The general process mirrors how epilepsy drug studies work and other conditions, because the participant protections are broadly similar across research.
Talk with your dermatologist first
A trial is a medical decision, so involve the clinician who manages your psoriasis. Your dermatologist can help you weigh whether a study fits your situation, what the realistic pros and cons are, and how it interacts with your current treatment. Importantly, never stop or change your existing psoriasis medications on your own to qualify for or join a trial; flares and rebound can follow abrupt changes. Let your care team and the research team coordinate any adjustments safely.
Frequently asked questions
Will a clinical trial cure my psoriasis? No trial can promise that. Psoriasis is a chronic condition, and trials test whether treatments are safe and effective; benefit is possible but not guaranteed.
Where do I find psoriasis trials? ClinicalTrials.gov is the main US registry. Academic dermatology programs and advocacy groups may also list opportunities.
Do I have to pay to join? Study treatment is often provided, but costs vary. Ask about expenses, travel, and what is and is not covered before enrolling.
Might I get a placebo? In some trials, yes. Randomized, blinded designs may assign you to a comparison or placebo group, which the consent process explains.
Can I leave a trial after starting? Yes. Participation is voluntary, and you can withdraw at any time without losing access to your standard care.
Should I stop my current treatment to qualify? Never do this on your own. Any change must be guided by your dermatologist and the research team.
This article is for general education and is not medical advice. Supplements and therapies affect people differently and can interact with medications or conditions. Talk to your doctor, pharmacist, or a licensed clinician before making changes to your health routine.
Sources
- ClinicalTrials.gov — US registry of clinical studies and how to search it
- National Institutes of Health (NIH) — basics of clinical trials and participant protections
- U.S. Food and Drug Administration (FDA) — clinical trial phases and drug development
- MedlinePlus — clinical trials and psoriasis overviews
- Mayo Clinic — psoriasis condition and treatment information